Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 16741–16760 of 17,529 recalls

March 25, 2013· Pallimed Solutions

Recalled Item: HCG Chorionic Gonadotropin

The Issue: Lack of Assurance of Sterility; FDA inspectional findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 25, 2013· Pallimed Solutions

Recalled Item: Bacteriostatic Water for Injection

The Issue: Lack of Assurance of Sterility; FDA inspectional findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 22, 2013· Actavis South Atlantic LLC

Recalled Item: buPROPion Hydrochloride Extended-Release Tablets (XL) 300 mg

The Issue: Failed USP Dissolution Test Requirements: Out-of-specification dissolution resul

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 22, 2013· Actavis Inc

Recalled Item: Diclofenac Sodium and Misoprostol Delayed-Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 22, 2013· Watson Laboratories, Inc.-(Actavis) - Florida

Recalled Item: Diclofenac Sodium and Misoprostol Delayed-Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 21, 2013· Precision Dose Inc.

Recalled Item: Children's Acetaminophen Oral Suspension

The Issue: Labeling: Not Elsewhere Classified: This unit dose product

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Test cyp 25 mg-estradiol cyp 7 mg/ml

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Acetylcysteine 20 % solution

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Pap 300 mg-phent 10 mg-prost 100 mcg

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Gentamicin buffered 36.4 mg/ml

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Injection vehicle

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Test cyp 25 mg-Estadiol valerate 15 mg/mL

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Cataract drops

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Test Cyp 200 mg/ml

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Test Cyp 100 mg/ml

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Test Cyp 10 mg/ml

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Test Cyp 25 mg-e(2) blend 12 mg/ml

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Test Cyp 50 mg-estradiol blend 22 mg

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Test Cyp 50 mg-estradiol cyp 7 mg/ml

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 20, 2013· Clinical Specialties Compounding Pharmacy

Recalled Item: Methylcobalamin 1250 mcg/ml

The Issue: Lack of Assurance of Sterility: FDA inspection findings

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund